| Literature DB >> 20339515 |
Junjie Hou1, Zhensheng Xie, Peng Xue, Ziyou Cui, Xiulan Chen, Jing Li, Tanxi Cai, Peng Wu, Fuquan Yang.
Abstract
Selecting an appropriate matrix solution is one of the most effective means of increasing the ionization efficiency of phosphoEntities:
Mesh:
Substances:
Year: 2010 PMID: 20339515 PMCID: PMC2842900 DOI: 10.1155/2010/759690
Source DB: PubMed Journal: J Biomed Biotechnol ISSN: 1110-7243
The peptides investigated in this study*.
| Peptide ID | Sequence No. | Sequence | [M+H]Theo+ | B+B |
|---|---|---|---|---|
| T | aa 106–119 | VPQLEIVPN | 1660.79 | 260 |
| T | aa 104 –119 | KYKVPQLEIVPN | 1951.95 | −710 |
| T | aa 43–58 | DIG | 1927.68 | 3960 |
| T | aa 59–79 | QMEAE | 2720.90 | 3680 |
| T | aa 37–58 | VNEL | 2678.02 | 3840 |
| T | aa 138–149 | TVDME | 1466.60 | −210 |
| T | aa 46–70 | NANEEEYSIG | 3008.02 | 7100 |
| T | aa 1–21 | KNTMEHV | 2747.00 | 2810 |
| T | aa 2–21 | NTMEHV | 2618.91 | 2350 |
| T | aa 33 –48 | FQ | 2061.82 | 6200 |
| T | aa 1–25 | RELEELNVPGEIVE | 3122.26 | −220 |
| T10 | aa 81–91 | ALNEINQFYQK | 1367.70 | −750 |
| T4 | aa 23–34 | FFVAPFPEVFGK | 1384.73 | −5530 |
| T3 | aa 8–22 | HQGLPQEVLNENLLR | 1759.59 | −590 |
| T11 | aa 91–100 | YLGYLEQLLR | 1267.71 | −6480 |
| T18 | aa 132–150 | EPMIGVNQELAYFYPELFR | 2316.14 | −6900 |
| — | VNQIG | 1368.44 | −310 | |
| — | SGSLHRI | 1465.48 | 2300 |
*Phosphopeptides in tryptic digest of βcasein and αcasein are denoted as Tβ1~2 and Tα1~9, respectively. The sites of phosphorylation are indicated with the letter “p” in the listed peptide sequences. T3, T4, T11, and T18 are nonphosphorylated peptide from αcasein S1. T10 is a nonphosphorylated peptide from α-casein S2. pT and pY are the synthesized standard phosphopeptides. [M+H]+ denotes the theoretical monoisotopic m/z mass. “B+B” means Bull and Breese Index for peptides calculated by the Masslynx software (Waters/Micromass).
Figure 1The MALDI mass spectra of the tryptic digest of α-casein (250 fmol on target) measured in positive ion mode with DHAP/DAHC matrix at different ratios (10 : 1 to 1 : 80). The signal intensity is magnified 10-fold in the m/z range from 2575 to 3025. The number of sites on each phosphopeptide is equal to the number of asterisks (*) shown.
Figure 2Top two views show the MALDI samples containing the phosphopeptide pT using (a) DHAP/DAHC matrix and (b) DHB/PA matrix. The two center pictures show the signal intensities of the phosphopeptides pT (250 fmol on target) measured with (c) DHAP/DAHC matrix and (d) DHB/PA matrix. The images only show a cut at signal intensity of 400 mv for clarity. The positions with signal intensities above 400 mv are indicated in purple. The bottom row (e) shows a schematic of the data acquisition method for investigating sample homogeneity of the matrix. In total, 196 positions were selected as a 14 × 14 spots array to cover the crystalline matrix/analyte layer, and 50 profiles (5 shots per profiles) were accumulated at each position.
Figure 3The MALDI mass spectra of the tryptic digest of (a) and (c) α-casein and (b) and (d) β-casein measured in positive (upper) and negative (lower) ion modes with the DHAP/DAHC matrix. The amount of the tryptic peptides mixture ranged from 5 fmol to 250 fmol on target. The signal intensity is magnified 5-fold in the m/z range from 2400 to 3150 in section a.
Figure 4The MALDI mass spectra of two synthesized phosphopeptides pT and pY mixed at equimolarity from 5 to 250 fmol on target, which were measured in positive (a) and negative (b) ion mode with DHAP/DAHC, respectively.
Figure 5Tryptic digests of α- (upper) and β-casein (lower) (12.5–250 fmol on target) were detected with DHAP/DAHC (a) and (c) and DHB/PA (b) and (d) by MALDI-TOF MS in positive mode. DHAP/DAHC positions were selected randomly in the outer ring of the sample; for DHB/PA, only signals in hot spots were collected. In total, 200 profiles were accumulated for each sample. The number of sites on each phosphopeptide was equal to the number of asterisks (*).
Figure 6The MALDI MS/MS spectra of phosphopeptides (a) Tβ1, (b) Tα3, and (c) Tβ2 (250 fmol for each on target) from α-casein and β-casein were obtained by MALDI-TOF/TOF MS. The sequential losses of H3PO4 from the parent ions are noted. The fragment patterns of the peptides are indicated in the magnified MS/MS spectra. “X” in the amino sequence shows a dehydroalanine residue converted from a phosphoserine residue by beta-elimination of H3PO4.
Figure 7The MALDI MS analysis of phosphopeptides from CDK1-treated human histone H1. MS spectra of the tryptic peptides from CDK1-treated histone H1 with the untreated (Figure 7(a)) and alkaline phosphatase-treated histone H1 (Figure 7(b)). The two panels on the right show the magnified spectra to indicate the two phosphopeptides labeled with asterisks (*). The MALDI-TOF/TOF-MS analysis of phosphorylation sites on the two monophosphopeptides VApTPKKASKPK, m/z 1234.7 (c), APTKKPKApTPVKK, m/z 1473.9 (d) from the CDK1-treated human histone H1. The neutral-loss peak of phosphopeptide was noted as [MH-H3PO4]+. The fragment patterns of peptides were shown in the magnified MS/MS spectra. “B” in the amino sequence indicates a dehydroamino-2-butyric acid residue converted from a phosphothreonine residue by beta-elimination of H3PO4. All the spectra were detected using DHAP/DAHC matrix in the positive mode.